Results overview: Found 4 records in 0.02 seconds.
Articles, 4 records found
Articles 4 records found  
1.
7 p, 716.5 KB Current professional standing of young medical oncologists in Spain : a nationwide survey by the Spanish Society of Medical Oncology + MIR section / Martinez, Domingo Antonio Sanchez (Instituto Murciano de Investigación Biosanitaria) ; Quilez-Cutillas, Aliica (Department of Medical Oncology, Can Misses Hospital, Área de Salud de Ibiza y Formentera (ASEF), Ibiza, Illes Balears Spain) ; Jimenez-Labaig, Pablo (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Sesma, Andrea (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; Tarazona, Noelia (Centro de Investigación Biomédica en Red de Cáncer) ; Pacheco-Barcia, Vilma (Torrejón University Hospital. Department of Medical Oncology) ; Obispo, Berta (Hospital Universitario Infanta Leonor) ; Páez, David (Institut d'Investigació Biomèdica Sant Pau) ; Quintanar, Teresa (Hospital General Universitario de Elche) ; Sanchez-Canovas, Manuel (Hospital General Universitario Morales Meseguer (Múrcia)) ; Fernández Montes, Ana (University Hospital Complex of Ourense (CHUO). Department of Medical Oncology) ; Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ; Rodriguez-Lescure, Alvaro (Elche University General Hospital. Department of Medical Oncology) ; Elez, Elena (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
There is a lack of knowledge about the career paths and employment situation of young medical oncologists. The aim of our study was to evaluate the current professional standing of these professionals in Spain. [...]
2022 - 10.1007/s12094-022-02989-3
Clinical & Translational Oncology, november 2022, p. 1-7  
2.
11 p, 515.9 KB Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain / Rodríguez-Lescure, A. (Hospital General Universitario de Elche) ; de la Peña, F. A. (Hospital General Universitario Morales Meseguer (Múrcia)) ; Aranda, E. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Calvo, A. (Hospital General Universitario Gregorio Marañón) ; Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ; Garrido, Pilar (Hospital Universitario Ramón y Cajal (Madrid)) ; Vera, Ruth (Complejo Hospitalario de Navarra) ; Universitat Autònoma de Barcelona
The Spanish Society of Medical Oncology (SEOM) has carried out a study to analyse the conditions of access to oncology drugs in clinical practice in Spain. For the first time, the access of predictive biomarkers has also been analyzed. [...]
2020 - 10.1007/s12094-020-02366-y
Clinical & Translational Oncology, Vol. 22 (june 2020) , p. 2253-2263  
3.
10 p, 777.7 KB Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain / Segui Palmer, Miquel Angel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Cruz, J. J. (Hospital Clínico Universitario (Salamanca)) ; Alba, Emilio (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Feliu, Jaime (Centro de Investigación Biomédica en Red de Cáncer) ; Jara Sánchez, Carlos (Hospital Universitario Fundación Alcorcón) ; Rivera, Fernando (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Rodriguez Lescure, A. (Hospital General Universitario de Elche) ; Lorenzo, A. (Hospital Universitario Puerto Real (Cadis)) ; Martin, M. (Centro de Investigación Biomédica en Red de Cáncer)
The Spanish Society of Medical Oncology (SEOM, for its Spanish acronym) would like to attest to the relevance of training in Oncology as part of the undergraduate education in Medicine program and issue recommendations to improve said training, with the aim of responding better to the challenges that cancer poses to our society. [...]
2019 - 10.1007/s12094-019-02230-8
Clinical & Translational Oncology, Vol. 22 (november 2019) , p. 1049-1058  
4.
10 p, 889.8 KB Predicting response and survival in chemotherapy-treated triple-negative breast cancer / Prat, A. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Lluch, Ana (Hospital Clínic Universitari (València)) ; Albanell Mestres, Joan (Universitat Pompeu Fabra) ; Barry, W. T. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Biostatistics and Computational Biology) ; Fan, C. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Chacón, José Ignacio (Hospital Virgen de la Salud (Toledo)) ; Parker, J. S. (University of North Carolina. Department of Genetics) ; Calvo, L.. (Complejo Hospitalario Universitario de A Coruña) ; Plazaola, A. (Department of Medical Oncology, Onkologikoa) ; Arcusa, Àngels (Consorci Sanitari de Terrassa. Departament d'Oncologia Mèdica) ; Seguí-Palmer, M. A. (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Burgués, Octavio (Hospital Clínic Universitari (València)) ; Ribelles, Nuria (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Rodriguez-Lescure, A. (Hospital General Universitario de Elche) ; Guerrero, A. (Fundació Institut Valencià d'Oncologia) ; Ruiz-Borrego, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Munárriz, Blanca (Hospital Universitari i Politècnic La Fe (València)) ; López, J. A. (Hospital San Camilo) ; Adamo, Barbara (Hospital Universitari Vall d'Hebron) ; Cheang, M. C. U. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Li, Y (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Hu, Z. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Gulley, M. L. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Vidal, M. J. (Hospital Universitari Vall d'Hebron) ; Pitcher, B. N. (Alliance Statistical and Data Center, Duke University) ; Liu, M. C. (Mayo Clinic. Department of Oncology) ; Citron, M. L. (ProHEALTH Care Associates, LLP) ; Ellis, M. J. (Washington University. Department of Oncology) ; Mardis, E. (Washington University. Department of Oncology) ; Vickery, T. (Washington University. Department of Oncology) ; Hudis, C. A. (Memorial Sloan Kettering Cancer Center) ; Winer, E. P. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Carey, L. A. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Caballero, Rosalía (Grupo Español de Investigación en Cáncer de Mama) ; Carrasco, E. (Grupo Español de Investigación en Cáncer de Mama) ; Martín, M. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Perou, Charles M. (University of North Carolina. Department of Pathology and Laboratory Medicine) ; Alba, Emilio (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia))
In this study, we evaluated the ability of gene expression profiles to predict chemotherapy response and survival in triple-negative breast cancer (TNBC). Gene expression and clinical-pathological data were evaluated in five independent cohorts, including three randomised clinical trials for a total of 1055 patients with TNBC, basal-like disease (BLBC) or both. [...]
2014 - 10.1038/bjc.2014.444
British Journal of Cancer, Vol. 111 (08 2014) , p. 1532-1541  

See also: similar author names
2 Rodriguez-Lescure, A.
4 Rodriguez-Lescure, Alvaro
4 Rodríguez-Lescure, Álvaro
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.